BIOMAT Database Logo BIOMAT Database Logo

Humoral pathogenesis of myasthenia gravis. 1987

D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

UI MeSH Term Description Entries
D007130 Immunoglobulin Idiotypes Unique genetically-controlled determinants present on ANTIBODIES whose specificity is limited to a single group of proteins (e.g., another antibody molecule or an individual myeloma protein). The idiotype appears to represent the antigenicity of the antigen-binding site of the antibody and to be genetically codetermined with it. The idiotypic determinants have been precisely located to the IMMUNOGLOBULIN VARIABLE REGION of both immunoglobin polypeptide chains. Idiotypes, Immunoglobulin,Ig Idiotypes,Idiotype, Ig,Idiotype, Immunoglobulin,Idiotypes, Ig,Ig Idiotype,Immunoglobulin Idiotype
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D009469 Neuromuscular Junction The synapse between a neuron and a muscle. Myoneural Junction,Nerve-Muscle Preparation,Junction, Myoneural,Junction, Neuromuscular,Junctions, Myoneural,Junctions, Neuromuscular,Myoneural Junctions,Nerve Muscle Preparation,Nerve-Muscle Preparations,Neuromuscular Junctions,Preparation, Nerve-Muscle,Preparations, Nerve-Muscle
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D001666 Binding Sites, Antibody Local surface sites on antibodies which react with antigen determinant sites on antigens (EPITOPES.) They are formed from parts of the variable regions of FAB FRAGMENTS. Antibody Binding Sites,Paratopes,Antibody Binding Site,Binding Site, Antibody,Paratope

Related Publications

D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
[Myasthenia gravis: pathogenesis].
May 1979, Revue medicale de la Suisse romande,
D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
[Pathogenesis of myasthenia gravis].
November 2006, No to shinkei = Brain and nerve,
D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
Pathogenesis of myasthenia gravis.
October 1971, British medical journal,
D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
Pathogenesis of myasthenia gravis.
May 1971, British medical journal,
D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
Pathogenesis of myasthenia gravis.
June 1971, British medical journal,
D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
Pathogenesis of myasthenia gravis.
May 1971, British medical journal,
D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
Pathogenesis of myasthenia gravis.
April 1971, British medical journal,
D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
[Pathogenesis of myasthenia gravis].
January 2000, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,
D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
Pathogenesis of myasthenia gravis.
January 1978, Muscle & nerve,
D B Drachman, and S de Silva, and D Ramsay, and A Pestronk
Pathogenesis of myasthenia gravis.
May 1997, Virchows Archiv : an international journal of pathology,
Copied contents to your clipboard!